BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18060576)

  • 1. N-acetylglucosaminyltransferase V mediates cell migration and invasion of mouse mammary tumor cells 4TO7 via RhoA and Rac1 signaling pathway.
    Zhao Y; Li J; Xing Y; Wang J; Lu C; Xin X; Geng M
    Mol Cell Biochem; 2008 Feb; 309(1-2):199-208. PubMed ID: 18060576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylglucosaminyltransferase V regulates extravillous trophoblast invasion through glycosylation of alpha5beta1 integrin.
    Yamamoto E; Ino K; Miyoshi E; Inamori K; Abe A; Sumigama S; Iwase A; Kajiyama H; Shibata K; Nawa A; Kikkawa F
    Endocrinology; 2009 Feb; 150(2):990-9. PubMed ID: 18845630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium.
    Lee J; Ko M; Joo CK
    J Cell Physiol; 2008 Aug; 216(2):520-6. PubMed ID: 18314880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylglucosaminyltransferase V negatively regulates integrin α5β1-mediated monocyte adhesion and transmigration through vascular endothelium.
    Yang HM; Yu C; Yang Z
    Int J Oncol; 2012 Aug; 41(2):589-98. PubMed ID: 22614033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase.
    Guo HB; Randolph M; Pierce M
    J Biol Chem; 2007 Jul; 282(30):22150-62. PubMed ID: 17537730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
    Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
    APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.
    Somanath PR; Byzova TV
    J Cell Physiol; 2009 Feb; 218(2):394-404. PubMed ID: 18853424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
    Huang Q; Shen HM; Ong CN
    Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway.
    Guo HB; Lee I; Bryan BT; Pierce M
    J Biol Chem; 2005 Mar; 280(9):8332-42. PubMed ID: 15615721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration.
    Guo HB; Lee I; Kamar M; Akiyama SK; Pierce M
    Cancer Res; 2002 Dec; 62(23):6837-45. PubMed ID: 12460896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
    Edlund S; Landström M; Heldin CH; Aspenström P
    Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
    Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
    J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP1B regulates axonal development by modulating Rho-GTPase Rac1 activity.
    Montenegro-Venegas C; Tortosa E; Rosso S; Peretti D; Bollati F; Bisbal M; Jausoro I; Avila J; Cáceres A; Gonzalez-Billault C
    Mol Biol Cell; 2010 Oct; 21(20):3518-28. PubMed ID: 20719958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
    Debidda M; Wang L; Zang H; Poli V; Zheng Y
    J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation.
    Oleinik NV; Helke KL; Kistner-Griffin E; Krupenko NI; Krupenko SA
    J Biol Chem; 2014 Sep; 289(38):26383-26394. PubMed ID: 25086046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.